HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postnatal virilization mimicking 21-hydroxylase deficiency in 3 very premature infants.

Abstract
Premature infants are known to have elevated 17-hydroxyprogesterone and adrenal androgen concentrations immediately after birth, but the levels decrease rapidly. Virilization of normal premature female infants as a result of these high androgens has not been described. Three premature female infants born at 24 to 25 weeks' gestation, with birth weights 550 to 880 g and significant neonatal complications were noted to develop clitoromegaly 2 weeks to 3 months after birth. All 3 had elevated 17-hydroxyprogesterone >100 nmol/L and testosterone >3 nmol/L concentrations. All were treated as simple virilizing 21-hydroxylase deficiency, but subsequent genetic analysis revealed no CYP21 mutations. Follow-up after discontinuation of treatment revealed no recurrent virilization and normal adrenal steroid levels. Postnatal virilization in sick premature girls may occur, and investigations may suggest 21-hydroxylase deficiency. Genetic analysis of CYP21 should be performed before the diagnosis is confirmed. Further studies are needed to better document the natural history and possible causes of postnatal adrenal androgen secretion in sick premature infants.
AuthorsRobert Couch, Rose Girgis
JournalPediatrics (Pediatrics) Vol. 129 Issue 5 Pg. e1364-7 (May 2012) ISSN: 1098-4275 [Electronic] United States
PMID22473363 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Testosterone
  • 17-alpha-Hydroxyprogesterone
Topics
  • 17-alpha-Hydroxyprogesterone (blood)
  • Adrenal Hyperplasia, Congenital (blood, diagnosis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Premature, Diseases (blood, diagnosis)
  • Testosterone (blood)
  • Virilism (blood, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: